Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
137991000087112 | FLUMIST QUADRIVALENT 0.2 milliliter intranasal spray AstraZeneca Canada (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
67951000087115 | FLUMIST QUADRIVALENT 0.2 milliliter intranasal spray AstraZeneca Canada | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
68491000087119 | Inf FLUMIST QUADRIVALENT AZC | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
73981000087113 | Inf FLUMIST QUADRIVALENT AZC | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway French module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
FLUMIST QUADRIVALENT 0.2 milliliter intranasal spray AstraZeneca Canada (real clinical drug) | Count of active ingredient | quatre | false | Inferred relationship | Some | ||
FLUMIST QUADRIVALENT 0.2 milliliter intranasal spray AstraZeneca Canada (real clinical drug) | a pour principe actif (attribut) | Antigen of live attenuated Influenza A virus subtype H1N1 (substance) | true | Inferred relationship | Some | 1 | |
FLUMIST QUADRIVALENT 0.2 milliliter intranasal spray AstraZeneca Canada (real clinical drug) | a pour principe actif (attribut) | Antigen of live attenuated Influenza B virus Victoria lineage (substance) | true | Inferred relationship | Some | 4 | |
FLUMIST QUADRIVALENT 0.2 milliliter intranasal spray AstraZeneca Canada (real clinical drug) | est un(e) (attribut) | Vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage live attenuated antigens in nasal dose form (medicinal product form) | true | Inferred relationship | Some | ||
FLUMIST QUADRIVALENT 0.2 milliliter intranasal spray AstraZeneca Canada (real clinical drug) | Has supplier | AstraZeneca Canada (supplier) | true | Inferred relationship | Some | ||
FLUMIST QUADRIVALENT 0.2 milliliter intranasal spray AstraZeneca Canada (real clinical drug) | a pour principe actif (attribut) | Live attenuated Influenza A virus subtype H3N2 antigen | true | Inferred relationship | Some | 2 | |
FLUMIST QUADRIVALENT 0.2 milliliter intranasal spray AstraZeneca Canada (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
FLUMIST QUADRIVALENT 0.2 milliliter intranasal spray AstraZeneca Canada (real clinical drug) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
FLUMIST QUADRIVALENT 0.2 milliliter intranasal spray AstraZeneca Canada (real clinical drug) | a pour principe actif (attribut) | Antigen of live attenuated Influenza B virus Yamagata lineage (substance) | true | Inferred relationship | Some | 3 | |
FLUMIST QUADRIVALENT 0.2 milliliter intranasal spray AstraZeneca Canada (real clinical drug) | est un(e) (attribut) | Vaccine product containing only Influenza virus 4 strains antigens (medicinal product) | false | Inferred relationship | Some | ||
FLUMIST QUADRIVALENT 0.2 milliliter intranasal spray AstraZeneca Canada (real clinical drug) | a pour principe actif (attribut) | Influenza virus vaccine (substance) | false | Inferred relationship | Some | 1 | |
FLUMIST QUADRIVALENT 0.2 milliliter intranasal spray AstraZeneca Canada (real clinical drug) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage nasal (forme pharmaceutique) | true | Inferred relationship | Some | ||
FLUMIST QUADRIVALENT 0.2 milliliter intranasal spray AstraZeneca Canada (real clinical drug) | est un(e) (attribut) | Intranasal influenza live virus vaccine | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Administered tradename codes for vaccines reference set (foundation metadata concept)